Septerna Inc Septerna Inc

Septerna Inc

SEPN

Rank in Stocks #5787
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops... Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves’ disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women’s health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Share Price
$42.60
Last synced: 2026-11-13
Market Cap
$2.00B
Change (1 day)
1.77%
Change (1 year)
79.22%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Category

Healthcare
EPS for Septerna Inc (SEPN)
EPS as of September 2026 TTM: $-1.29
According to Septerna Inc's latest financial reports, its current EPS (TTM) is $-1.29. At the end of 2025 the company had an EPS of $-1.10, an increase over its 2024 EPS of $-1.93.
EPS history for Septerna Inc from 2023 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-1.29 17.27%
2025 $-1.10 -43.01%
2024 $-1.93 -6,732.30%
2023 $0.03 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 -31.01%
US
$15.66 -1,313.95%
US
$-7.07 448.06%
US
$-5.29 310.08%
AU
$12.73 -1,086.99%
BE

Questions about Septerna Inc's earnings per share (EPS)

What is Septerna Inc's earnings per share (EPS)?

Septerna Inc's earnings per share (EPS) over the last twelve months is $-1.29, as of Sep 2026.

What was Septerna Inc's earnings per share (EPS) in 2025?

In 2025, Septerna Inc's earnings per share (EPS) was $-1.10, compared with $-1.93 in 2024.

How has Septerna Inc's earnings per share (EPS) changed since 2023?

From 2023 to 2025, Septerna Inc's earnings per share (EPS) was highest in 2023 ($0.03) and lowest in 2024 ($-1.93).

How does Septerna Inc's earnings per share (EPS) compare with similar companies?

Septerna Inc's earnings per share (EPS) ($-1.29) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.